CIK 0001534133 · Non-accelerated filer<br>Smaller reporting company
CalciMedica, Inc.
Sign in to watch- Ticker
- CALC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 452120079
- Phone
- 858-952-5500
- Business address
- 505 COAST BOULEVARD SOUTH, SUITE 307, LA JOLLA, CA, 92037
- Former names
- CalciMedica, Inc. /DE/, GRAYBUG VISION, INC., GRAYBUG, Inc., GRAYBUG LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-08-27 | WILSON ROBERT N Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-08-27 | Dunn Michael J. President and COO | Grant or award · Employee Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2024-08-27 | Stauderman Kenneth A. Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +62,500 | 62,500 | ||
| 2024-08-27 | Roberts Eric W CHIEF BUSINESS OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +77,500 | 77,500 | ||
| 2024-08-27 | Hebbar Sudarshan Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +82,500 | 82,500 | ||
| 2024-08-27 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Grant or award · Employee Stock Option (Right to Buy) | +115,000 | 115,000 | ||
| 2024-08-27 | Leheny A. Rachel CHIEF EXECUTIVE OFFICER | Purchase | +1,000 | $4.19 | $4K | 110,926 |
| 2024-08-23 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +2,000 | $3.58 | $7K | 46,894 |
| 2024-08-23 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +3,000 | $3.57 | $11K | 13,223 |
| 2024-08-23 | WILSON ROBERT N Director | Purchase | +54,000 | $3.72 | $201K | 364,196 |
| 2024-08-21 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,000 | $4.04 | $20K | 44,894 |
| 2024-06-28 | WILSON ROBERT N Director | Purchase | +51,278 | $3.52 | $180K | 310,196 |
| 2024-06-27 | WILSON ROBERT N Director | Purchase | +8,443 | $3.23 | $27K | 258,918 |
| 2024-06-27 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +5,000 | $3.22 | $16K | 10,223 |
| 2024-05-17 | Geffken Daniel E. Interim CFO | Grant or award · Warrant | +10,000 | 10,000 | ||
| 2024-04-02 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +3,254 | $3.90 | $13K | 39,894 |
| 2024-04-01 | Roberts Eric W CHIEF BUSINESS OFFICER | Purchase | +746 | $3.90 | $3K | 36,640 |
| 2024-03-28 | Guerard Frederic Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-03-28 | BJERKHOLT ERIC Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2024-03-28 | Shaw Allan Director | Grant or award · Director Stock Option (Right to Buy) | +10,000 | 10,000 |
Page 7 of 29 · 565 trades